Background Although previous studies have helped define the natural history of Duchenne
Muscular Dystrophy (DMD)-associated cardiomyopathy, the myocardial pathobiology …

Background Duchenne muscular dystrophy (DMD) cardiomyopathy is a progressive disease
for which there is no cure. Disease-specific therapies are needed that can be initiated before …

Background The progressive cardiomyopathy that develops in boys with Duchenne and
Becker muscular dystrophy (DMD/BMD) is presumed to be a secondary consequence of the …

The cardiac disease ubiquitously associated in Duchenne Muscular Dystrophy (DMD) has
traditionally been considered a progressive dilated cardiomyopathy (DCM). However, left …

Background Duchenne muscular dystrophy (DMD) is an X-linked, inherited disorder causing
dilated cardiomyopathy with variable onset and progression. Currently we lack objective …

Background Progressive cardiomyopathy accounts for almost all mortality among Duchenne
muscular dystrophy (DMD) patients. ‍ Thus, our aim was to comprehensively characterize …

BACKGROUND: In young patients (aged< 12 years) with Duchenne muscular dystrophy
(DMD), cardiac systolic function is generally described to be within the normal range. Recent …

Background This study was designed to assess whether cardiovascular magnetic
resonance imaging (CMR) in Duchenne muscular dystrophy carriers (DMDc) may index any …

Background Cardiomyopathy (CMP) is the most common cause of mortality in Duchenne
muscular dystrophy (DMD), though the age of onset and clinical progression vary. We …

Objective To examine the extent of cardiac muscle and sternocleidomastoid muscle (SCM)
involvement detected by MRI measurement of T2 relaxation time in patients with Duchenne …